Jul 20, 2022
337:333
For every 333 shares held, investors received 337. The price per share adjusted from $374.50 to $370.05.
The split itself did not change the total investment value.
Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617) operates in the Medical distributors industry.
Gongwin Biopharm Holdings Co., Ltd. company overviewGongwin Biopharm Holdings Co., Ltd.'s most recent stock split was on July 20, 2022. It was a 337-for-333 forward split, so shareholders received 337 shares for every 333 they held.
Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617) has split its stock 3 times: a 271-for-268 split on April 3, 2018, a 127-for-124 split on September 17, 2020, and a 337-for-333 split on July 20, 2022.
Gongwin Biopharm Holdings Co., Ltd. has split its stock 3 times. This history records 3 forward splits between April 3, 2018 and July 20, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Gongwin Biopharm Holdings Co., Ltd.'s 337-for-333 split on July 20, 2022, every 333 shares became 337 shares.
Gongwin Biopharm Holdings Co., Ltd. has not announced a new split in our records. Its most recent split was on July 20, 2022, 4 years ago. Companies announce splits in advance, and any new TPEX:6617 split will appear on this page.
Already premium?